Philip Bejon/PLoS One

MALDI-TOF MS for malaria vector surveillance: A cost-comparison analysis using a decision-tree approach.Karisa, J. Rist, C. Tuwei, M. Ominde, K. Bartilol, B. Ondieki, Z. Musani, H. Wanjiku, C. Mwangangi, J. Mbogo, C. Rono, M. Bejon, P. Maia, M.
PLoS One, (2025). 20:e0335764

Induction of an early IFN-gamma cellular response and high plasma levels of SDF-1alpha are inversely associated with COVID-19 severity and residence in rural areas in Kenyan patients.Wanjiku, P. Orindi, B. Kimotho, J. Sayed, S. Shah, R. Saleh, M. Mwacharo, J. Maronga, C. Olouch, V. Karanu, A. Shah, J. Nneka, Z. Ochola-Oyier, L. I. Abdi, A. I. Dunachie, S. Bejon, P. Nduati, E. W. Ndungu, F. M.
PLoS One, (2025). 20:e0316967

Making MALDI-TOF MS for entomological parameters accessible: A practical guide for in-house library creation.Karisa, J. Tuwei, M. Ominde, K. Bartilol, B. Ondieki, Z. Musani, H. Rono, M. Mbogo, C. Bejon, P. Mwangangi, J. Wanjiku, C. Maia, M.
PLoS One, (2025). 20:e0330605

Correlations between three ELISA protocols measurements of RTS,S/AS01-induced anti-CSP IgG antibodies.Mugo, R. M. Orindi, B. Shee, F. M. Bellamy, D. Mwacharo, J. Ewer, K. J. Bejon, P. Ndungu, F. M.
PLoS One, (2023). 18:e0286117

Validation of saline, PBS and a locally produced VTM at varying storage conditions to detect the SARS-CoV-2 virus by qRT-PCR.Ngetsa, C. Osoti, V. Okanda, D. Marura, F. Shah, K. Karanja, H. Mugo, D. Gitonga, J. Mutunga, M. Lewa, C. Orindi, B. Bejon, P. Ochola-Oyier, L. I.
PLoS One, (2023). 18:e0280685

Sero-surveillance for IgG to SARS-CoV-2 at antenatal care clinics in three Kenyan referral hospitals: Repeated cross-sectional surveys 2020-21.Lucinde, R. K. Mugo, D. Bottomley, C. Karani, A. Gardiner, E. Aziza, R. Gitonga, J. N. Karanja, H. Nyagwange, J. Tuju, J. Wanjiku, P. Nzomo, E. Kamuri, E. Thuranira, K. Agunda, S. Nyutu, G. Etyang, A. O. Adetifa, I. M. O. Kagucia, E. Uyoga, S. Otiende, M. Otieno, E. Ndwiga, L. Agoti, C. N. Aman, R. A. Mwangangi, M. Amoth, P. Kasera, K. Nyaguara, A. Ng'ang'a, W. Ochola, L. B. Namdala, E. Gaunya, O. Okuku, R. Barasa, E. Bejon, P. Tsofa, B. Ochola-Oyier, L. I. Warimwe, G. M. Agweyu, A. Scott, J. A. G. Gallagher, K. E.
PLoS One, (2022). 17:e0265478

Determinants of improvement trends in health workers' compliance with outpatient malaria case-management guidelines at health facilities with available "test and treat" commodities in Kenya.Amboko, B. Stepniewska, K. Malla, L. Machini, B. Bejon, P. Snow, R. W. Zurovac, D.
PLoS One, (2021). 16:e0259020

The relationship between facility-based malaria test positivity rate and community-based parasite prevalence.Kamau, A. Mtanje, G. Mataza, C. Malla, L. Bejon, P. Snow, R. W.
PLoS One, (2020). 15:e0240058

First field efficacy trial of the ChAd63 MVA ME-TRAP vectored malaria vaccine candidate in 5-17 months old infants and children.Tiono, A. B. Nebie, I. Anagnostou, N. Coulibaly, A. S. Bowyer, G. Lam, E. Bougouma, E. C. Ouedraogo, A. Yaro, J. B. B. Barry, A. Roberts, R. Rampling, T. Bliss, C. Hodgson, S. Lawrie, A. Ouedraogo, A. Imoukhuede, E. B. Ewer, K. J. Viebig, N. K. Diarra, A. Leroy, O. Bejon, P. Hill, A. V. S. Sirima, S. B.
PLoS One, (2018). 13:e0208328

Safety, Immunogenicity and Efficacy of Prime-Boost Vaccination with ChAd63 and MVA Encoding ME-TRAP against Plasmodium falciparum Infection in Adults in Senegal.Mensah, V. A. Gueye, A. Ndiaye, M. Edwards, N. J. Wright, D. Anagnostou, N. A. Syll, M. Ndaw, A. Abiola, A. Bliss, C. Gomis, J. F. Petersen, I. Ogwang, C. Dieye, T. Viebig, N. K. Lawrie, A. M. Roberts, R. Nicosia, A. Faye, B. Gaye, O. Leroy, O. Imoukhuede, E. B. Ewer, K. J. Bejon, P. Hill, A. V. Cisse, B. Mvvc group
PLoS One, (2016). 11:e0167951

Changing Malaria Prevalence on the Kenyan Coast since 1974: Climate, Drugs and Vector Control.Snow, R. W. Kibuchi, E. Karuri, S. W. Sang, G. Gitonga, C. W. Mwandawiro, C. Bejon, P. Noor, A. M.
PLoS One, (2015). 10:e0128792

Avidity of anti-circumsporozoite antibodies following vaccination with RTS,S/AS01E in young children.Olotu, A. Clement, F. Jongert, E. Vekemans, J. Njuguna, P. Ndungu, F. M. Marsh, K. Leroux-Roels, G. Bejon, P.
PLoS One, (2014). 9:e115126

Plasmodium falciparum malaria in children aged 0-2 years: the role of foetal haemoglobin and maternal antibodies to two asexual malaria vaccine candidates (MSP3 and GLURP).Kangoye, D. T. Nebie, I. Yaro, J. B. Debe, S. Traore, S. Ouedraogo, O. Sanou, G. Soulama, I. Diarra, A. Tiono, A. Marsh, K. Sirima, S. B. Bejon, P.
PLoS One, (2014). 9:e107965

A genome wide association study of Plasmodium falciparum susceptibility to 22 antimalarial drugs in Kenya.Wendler, J. P. Okombo, J. Amato, R. Miotto, O. Kiara, S. M. Mwai, L. Pole, L. O'Brien, J. Manske, M. Alcock, D. Drury, E. Sanders, M. Oyola, S. O. Malangone, C. Jyothi, D. Miles, A. Rockett, K. A. MacInnis, B. L. Marsh, K. Bejon, P. Nzila, A. Kwiatkowski, D. P.
PLoS One, (2014). 9:e96486

The relationship between RTS,S vaccine-induced antibodies, CD4(+) T cell responses and protection against Plasmodium falciparum infection.White, M. T. Bejon, P. Olotu, A. Griffin, J. T. Riley, E. M. Kester, K. E. Ockenhouse, C. F. Ghani, A. C.
PLoS One, (2013). 8:e61395

Safety and immunogenicity of heterologous prime-boost immunisation with Plasmodium falciparum malaria candidate vaccines, ChAd63 ME-TRAP and MVA ME-TRAP, in healthy Gambian and Kenyan adults.Ogwang, C. Afolabi, M. Kimani, D. Jagne, Y. J. Sheehy, S. H. Bliss, C. M. Duncan, C. J. Collins, K. A. Garcia Knight, M. A. Kimani, E. Anagnostou, N. A. Berrie, E. Moyle, S. Gilbert, S. C. Spencer, A. J. Soipei, P. Mueller, J. Okebe, J. Colloca, S. Cortese, R. Viebig, N. K. Roberts, R. Gantlett, K. Lawrie, A. M. Nicosia, A. Imoukhuede, E. B. Bejon, P. Urban, B. C. Flanagan, K. L. Ewer, K. J. Chilengi, R. Hill, A. V. Bojang, K.
PLoS One, (2013). 8:e57726

The ratio of monocytes to lymphocytes in peripheral blood correlates with increased susceptibility to clinical malaria in Kenyan children.Warimwe, G. M. Murungi, L. M. Kamuyu, G. Nyangweso, G. M. Wambua, J. Naranbhai, V. Fletcher, H. A. Hill, A. V. Bejon, P. Osier, F. H. Marsh, K.
PLoS One, (2013). 8:e57320

Lack of avidity maturation of merozoite antigen-specific antibodies with increasing exposure to Plasmodium falciparum amongst children and adults exposed to endemic malaria in Kenya.Ibison, F. Olotu, A. Muema, D. M. Mwacharo, J. Ohuma, E. Kimani, D. Marsh, K. Bejon, P. Ndungu, F. M.
PLoS One, (2012). 7:e52939

A statistical interaction between circumsporozoite protein-specific T cell and antibody responses and risk of clinical malaria episodes following vaccination with RTS,S/AS01E.Ndungu, F. M. Mwacharo, J. Kimani, D. Kai, O. Moris, P. Jongert, E. Vekemans, J. Olotu, A. Bejon, P.
PLoS One, (2012). 7:e52870

Estimating individual exposure to malaria using local prevalence of malaria infection in the field.Olotu, A. Fegan, G. Wambua, J. Nyangweso, G. Ogada, E. Drakeley, C. Marsh, K. Bejon, P.
PLoS One, (2012). 7:e32929